川宁生物(301301.SZ)：上半年净利润4.55亿元 同比下降40.64%

Core Viewpoint - Chuaning Bio (301301.SZ) reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its operational performance [1] Financial Performance - The company achieved a revenue of 2.349 billion yuan, representing a year-on-year decrease of 26.50% [1] - The net profit attributable to shareholders was 455 million yuan, down 40.64% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 456 million yuan, reflecting a 40.38% year-on-year decline [1] - Basic earnings per share stood at 0.20 yuan [1]